Pablo Cristini

Articles by Pablo Cristini

25 March 2013

Difficult, but worth it

In his second Roundtable essay, Alexandr Vurim characterized me as representing a "conventional perspective" toward converting research reactors to low-enriched uranium (LEU) from highly enriched uranium (HEU).

21 February 2013

Conversion to LEU: Petals and thorns

As the essays published in this Roundtable so far have established, converting research reactors and fission radioisotope production facilities to the use of low-enriched uranium (LEU) can involve a number of difficult challenges.

6 February 2013

How to dispense with highly enriched uranium

About 85 percent of all diagnostic nuclear medical procedures, amounting to 30 million procedures a year, utilize technetium 99, a metastable medical isotope. This is the decay product of molybdenum 99, which is considered the most important radioisotope employed in nuclear medicine.

5 February 2013

Highly enriched uranium: Less is more

Charles PianiPablo CristiniAlexandr Vurim

A number of high-profile initiatives seek to reduce the possibility of nuclear proliferation and terrorism by minimizing the use of highly enriched uranium (HEU) in civilian applications.